Why is your research important and how will it influence the understanding and treatment of MS?
In MS, the immune system mistakenly attacks and destroys myelin in the central nervous system (CNS), slowing neural communication and leaving the underlying fibres vulnerable to damage. With ongoing myelin loss, these unprotected nerves begin to degenerate, leading to the progressive and irreversible disability seen in advanced MS, even when inflammation is controlled. There is an urgent and unmet need for treatments that actively promote myelin repair.
My research takes an innovative approach to this challenge by pinpointing the precise stages of oligodendrocyte development, as well as the downstream molecules that can be targeted and manipulated to enhance myelin production in MS. Ultimately, the outcomes of this project will be crucial in paving the way for targeted remyelination therapies, with the potential to transform MS treatment by complementing immune-modulating approaches with effective brain repair.